Spruce Street Capital LP — 13F Holdings

2026 Q3  ·  39 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Spruce Street Capital LP maintained a portfolio of 39 distinct positions. The most significant new addition was ENTERA BIO LTD, now representing 5.19% of the total fund value. They heavily accumulated shares in ZAI LAB LTD, increasing the position by 273.4%. The fund also reduced its exposure to RESEARCH ALLIANCE CORP III by 70.0%.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
39
Quarter
2026 Q3
Top Holding
KNSA (10.9%)
Top 10 Concentration
64.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-39 of 39

Spruce Street Capital LP Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
KNSA
KINIKSA PHARMAC...
Healthcare 10.89% 11.52% #1
Prev: #1
7.0
—
no change no change
P
S
918,070 $68,497,203
$47.58 +102.4%
$74.61 +29.1%
2025 Q4 13F Filing 2026-09-30 2026-11-13
LBRX
LB PHARMACEUTIC...
Healthcare 8.56% 8.76% #2 1
Prev: #3
5.4
—
28,620 2.1%
P
S
1,404,779 $53,863,456 2025 Q4 13F Filing 2026-09-30 2026-11-13
RLAY
RELAY THERAPEUT...
Healthcare 8.56% 10.95% #3 1
Prev: #2
5.4
—
no change no change
P
S
2,984,125 $53,863,456 2025 Q4 13F Filing 2026-09-30 2026-11-13
ANRO
ALTO NEUROSCIEN...
Healthcare 6.81% 7.01% #4 1
Prev: #5
5.7
—
323,511 23.9%
P
S
1,676,558 $42,802,526 2025 Q4 13F Filing 2026-09-30 2026-11-13
ALKS
ALKERMES PLC
Healthcare 6.11% 5.59% #5 2
Prev: #7
5.9
—
404,595 74.4%
P
S
948,471 $38,432,045 2026 Q1 13F Filing 2026-09-30 2026-11-13
ENTX
ENTERA BIO LTD
Healthcare 5.19% — #6
Prev: #—
5.6
—
11,213,455 —
NEW
11,213,455 $32,631,154 2026 Q3 13F Filing 2026-09-30 2026-11-13
DNTH
DIANTHUS THERAP...
Healthcare 4.97% 6.79% #7 1
Prev: #6
3.0
—
no change no change
P
S
354,816 $31,241,549 2025 Q4 13F Filing 2026-09-30 2026-11-13
SVRA
SAVARA INC
Healthcare 4.42% 4.17% #8
Prev: #8
4.8
—
1,929,365 55.9%
P
S
5,381,941 $27,770,816 2025 Q4 13F Filing 2026-09-30 2026-11-13
ZLAB
ZAI LAB LTD
Healthcare 4.36% 1.04% #9 15
Prev: #24
4.7
—
763,048 273.4%
P
S
1,042,158 $27,450,442 2026 Q2 13F Filing 2026-09-30 2026-11-13
RLMD
RELMADA THERAPE...
Healthcare 4.14% 8.68% #10 6
Prev: #4
3.7
—
520,863 8.1%
P
S
6,912,191 $26,058,960 2025 Q4 13F Filing 2026-09-30 2026-11-13
PCVX
VAXCYTE INC
Healthcare 2.77% 3.49% #11 2
Prev: #9
2.1
—
no change no change
P
S
306,047 $17,414,074 2025 Q4 13F Filing 2026-09-30 2026-11-13
OBX
OBSIDIAN THERAP...
Healthcare 2.73% — #12
Prev: #—
4.6
—
1,249,943 —
NEW
1,249,943 $17,161,717 2026 Q3 13F Filing 2026-09-30 2026-11-13
ELVN
ENLIVEN THERAPE...
Healthcare 2.40% 3.28% #13 3
Prev: #10
2.0
—
no change no change
P
S
329,006 $15,081,635 2025 Q4 13F Filing 2026-09-30 2026-11-13
ENTA
ENANTA PHARMACE...
Healthcare 2.28% 3.11% #14 3
Prev: #11
1.9
—
no change no change
P
S
1,088,731 $14,349,475 2025 Q4 13F Filing 2026-09-30 2026-11-13
SRZN
SURROZEN INC
Healthcare 2.21% 2.20% #15 1
Prev: #14
1.9
—
no change no change
P
S
432,040 $13,903,047 2025 Q4 13F Filing 2026-09-30 2026-11-13
SGMT
SAGIMET BIOSCIE...
Healthcare 2.20% — #16
Prev: #—
4.4
—
1,400,000 —
NEW
1,400,000 $13,832,000 2026 Q3 13F Filing 2026-09-30 2026-11-13
YARW
YARROW BIOSCIEN...
Healthcare 2.17% — #17
Prev: #—
4.4
—
607,382 —
NEW
607,382 $13,678,243 2026 Q3 13F Filing 2026-09-30 2026-11-13
IFRX
INFLARX NV
Healthcare 1.74% 2.35% #18 5
Prev: #13
2.7
—
733,972 13.7%
P
S
6,086,170 $10,955,106 2026 Q2 13F Filing 2026-09-30 2026-11-13
KRSA
KORSANA BIOSCIE...
Healthcare 1.64% — #19
Prev: #—
4.2
—
338,951 —
NEW
338,951 $10,304,110 2026 Q3 13F Filing 2026-09-30 2026-11-13
CATX
PERSPECTIVE THE...
Healthcare 1.62% 2.47% #20 8
Prev: #12
1.6
—
no change no change
P
S
3,693,931 $10,158,310 2026 Q1 13F Filing 2026-09-30 2026-11-13
ANTX
AN2 THERAPEUTIC...
Healthcare 1.48% 1.58% #21 2
Prev: #19
2.6
—
90,938 5.5%
P
S
1,752,011 $9,320,699 2026 Q1 13F Filing 2026-09-30 2026-11-13
IKT
INHIBIKASE THER...
Healthcare 1.17% 1.43% #22 1
Prev: #21
1.5
—
no change no change
P
S
3,581,603 $7,360,194 2025 Q4 13F Filing 2026-09-30 2026-11-13
SABS
SAB BIOTHERAPEU...
Healthcare 1.11% 1.68% #23 5
Prev: #18
1.4
—
no change no change
P
S
2,198,502 $6,969,251 2025 Q4 13F Filing 2026-09-30 2026-11-13
IPSC
CENTURY THERAPE...
Healthcare 1.10% 1.95% #24 8
Prev: #16
1.4
—
no change no change
P
S
4,059,054 $6,940,982 2025 Q4 13F Filing 2026-09-30 2026-11-13
ERAS
ERASCA INC
Healthcare 0.98% 1.52% #25 5
Prev: #20
1.4
—
no change no change
P
S
422,543 $6,194,480 2025 Q4 13F Filing 2026-09-30 2026-11-13
ACHV
ACHIEVE LIFE SC...
Healthcare 0.95% 0.94% #26 1
Prev: #25
1.4
—
no change no change
P
S
736,637 $5,959,393 2026 Q2 13F Filing 2026-09-30 2026-11-13
NERV
MINERVA NEUROSC...
Healthcare 0.88% 1.80% #27 10
Prev: #17
1.4
—
no change no change
P
S
1,655,500 $5,545,925 2025 Q4 13F Filing 2026-09-30 2026-11-13
N/A
RESEARCH ALLIAN...
Unknown 0.86% 1.05% #28 6
Prev: #22
1.3
—
no change no change
P
S
500,000 $5,415,000 — 13F Filing 2026-09-30 2026-11-13
N/A
RESEARCH ALLIAN...
Unknown 0.86% — #29
Prev: #—
3.8
—
450,000 —
NEW
450,000 $5,400,000 — 13F Filing 2026-09-30 2026-11-13
N/A
HELIX ACQUISITI...
Unknown 0.84% 1.04% #30 7
Prev: #23
1.3
—
no change no change
P
S
500,000 $5,310,000 — 13F Filing 2026-09-30 2026-11-13
N/A
ATTOVIA THERAPE...
Unknown 0.62% — #31
Prev: #—
3.7
—
228,295 —
NEW
228,295 $3,912,976 — 13F Filing 2026-09-30 2026-11-13
ALEC
ALECTOR INC
Healthcare 0.62% 0.83% #32 5
Prev: #27
1.2
—
no change no change
P
S
2,101,068 $3,886,976 2025 Q4 13F Filing 2026-09-30 2026-11-13
N/A
TCGX ACQUISITIO...
Unknown 0.60% — #33
Prev: #—
3.7
—
300,000 —
NEW
300,000 $3,753,000 — 13F Filing 2026-09-30 2026-11-13
LXEO
LEXEO THERAPEUT...
Healthcare 0.50% 0.85% #34 8
Prev: #26
1.2
—
no change no change
P
S
928,593 $3,138,644 2025 Q4 13F Filing 2026-09-30 2026-11-13
ALMS
ALUMIS INC
Healthcare 0.46% 2.17% #35 20
Prev: #15
1.2
—
no change no change
P
S
392,574 $2,901,122 2026 Q1 13F Filing 2026-09-30 2026-11-13
CRVS
CORVUS PHARMACE...
Healthcare 0.42% 0.68% #36 7
Prev: #29
1.2
—
no change no change
P
S
231,585 $2,667,859 2026 Q1 13F Filing 2026-09-30 2026-11-13
N/A
JATT II ACQUISI...
Unknown 0.29% 0.36% #37 7
Prev: #30
1.1
—
no change no change
P
S
160,000 $1,799,200 — 13F Filing 2026-09-30 2026-11-13
N/A
JATT III ACQUIS...
Unknown 0.26% — #38
Prev: #—
3.6
—
150,000 —
NEW
150,000 $1,653,000 — 13F Filing 2026-09-30 2026-11-13
LONA
LEONABIO INC
Healthcare 0.22% 0.71% #39 11
Prev: #28
1.1
—
no change no change
P
S
393,701 $1,405,513 2025 Q4 13F Filing 2026-09-30 2026-11-13
Showing 1-39 of 39 holdings

Unlock Full Spruce Street Capital LP Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →